Jacklynn V. Egger
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- COVID-19 and healthcare impacts
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 14
- Lung Cancer Research Studies 8
- Cancer-related Molecular Pathways 2
- COVID-19 and healthcare impacts 2
-
- Lung Cancer Treatments and Mutations 5
- Occupational and environmental lung diseases 5
- Co-authors
- Matthew David Hellmann (6 shared papers)Charles Rudin (9 shared papers)Hira A. Rizvi (5 shared papers)William David Travis (6 shared papers)Jennifer L. Sauter (7 shared papers)Natasha Rekhtman (6 shared papers)Jia Luo (3 shared papers)Amanda Beras (2 shared papers)
- Journals
- Journal of Thoracic Oncology (8 papers)Clinical Cancer Research (5 papers)Annals of Oncology (4 papers)Nature Cancer (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Jacklynn V. Egger
34 papers receiving 3.5k citations
Jacklynn V. Egger's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 2k
- Pulmonary and Respiratory Medicine 712
- Health Informatics 48
- Cancer Research 234
- Molecular Biology 630
Countries citing papers authored by Jacklynn V. Egger
This map shows the geographic impact of Jacklynn V. Egger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacklynn V. Egger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacklynn V. Egger more than expected).
Fields of papers citing papers by Jacklynn V. Egger
This network shows the impact of papers produced by Jacklynn V. Egger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacklynn V. Egger. The network helps show where Jacklynn V. Egger may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacklynn V. Egger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization Hit paper breakdown → | 2020 | 397 |
| 2 | The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution Hit paper breakdown → | 2020 | 385 |
| 3 | Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer Hit paper breakdown → | 2021 | 310 |
| 4 | Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status Hit paper breakdown → | 2021 | 297 |
| 5 | Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer Hit paper breakdown → | 2022 | 278 |
| 6 | 2020 | 251 | |
| 7 | 2020 | 233 | |
| 8 | 2020 | 197 | |
| 9 | 2020 | 197 | |
| 10 | 2022 | 100 | |
| 11 | 2021 | 93 | |
| 12 | 2022 | 85 | |
| 13 | 2023 | 79 | |
| 14 | 2023 | 69 | |
| 15 | 2022 | 68 | |
| 16 | 2021 | 67 | |
| 17 | 2022 | 66 | |
| 18 | 2021 | 64 | |
| 19 | 2021 | 42 | |
| 20 | 2022 | 41 |
About Jacklynn V. Egger
Jacklynn V. Egger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Infectious Diseases, having authored 34 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (5 papers), Occupational and environmental lung diseases (5 papers), Cancer-related Molecular Pathways (2 papers), COVID-19 and healthcare impacts (2 papers), Intraperitoneal and Appendiceal Malignancies (2 papers) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Oncology (2k citations), Pulmonary and Respiratory Medicine (712 citations), Health Informatics (48 citations), Cancer Research (234 citations) and Molecular Biology (630 citations). Jacklynn V. Egger has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Matthew David Hellmann, Charles Rudin, Hira A. Rizvi, William David Travis, Jennifer L. Sauter, Natasha Rekhtman, Jia Luo, Amanda Beras, Wei-Chu Victoria Lai and Isabel Ruth Preeshagul. Their work appears in journals such as Journal of Thoracic Oncology, Clinical Cancer Research, Annals of Oncology, Nature Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.